Clinical Trial Update: R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

A phase 2 trial of R-CHOP-B (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone plus Bevacizumab) for diffuse large B-cell lymphoma has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Non-Hodgkin's Lymphoma, B-cell Lymphoma | Phase 2 | Status: TERMINATED